Evangelisches Krankenhaus Lippstadt
Hospital
Location:
Lippstadt,
Germany (DE)
Risk-Adapted Neoadjuvant Chemoradiotherapy in Rectal Cancer: Final Report of the OCUM Study (2023)
Ruppert R, Junginger T, Kube R, Strassburg J, Lewin A, Baral J, Maurer CA, et al.
Journal article
Selection of patients with rectal cancer for neoadjuvant therapy using pre-therapeutic MRI-Results from OCUM trial (2022)
Stelzner S, Ruppert R, Kube R, Strassburg J, Lewin A, Baral J, Maurer CA, et al.
Journal article
MRI-Based Use of Neoadjuvant Chemoradiotherapy in Rectal Carcinoma: Surgical Quality and Histopathological Outcome of the OCUM Trial (2019)
Kreis ME, Ruppert R, Kube R, Strassburg J, Lewin A, Baral J, Maurer CA, et al.
Journal article
Spincter preservation after selective chemoradiotherapy of rectal cancer : Interim results of the OCUM study (2015)
Baral J, Schon MR, Ruppert R, Ptok H, Strassburg J, Brosi P, Kreis ME, et al.
Journal article